Antiviral effectiveness and safety of azvudine in hospitalized SARS‐CoV‐2 patients with pre‐existing chronic respiratory diseases: A multicenter, retrospective cohort study

Antiviral effectiveness and safety of azvudine in hospitalized SARS‐CoV‐2 patients with pre‐existing chronic respiratory diseases: A multicenter, retrospective cohort study

Abstract Although azvudine has become a priority in the treatment of SARS‐CoV‐2, its effectiveness and safety among COVID‐19 patients who already have chronic respiratory diseases (CRDs) have not been sufficiently validated. A retrospective, multicenter cohort study involving 10 hospitals in Henan P...

Full description

Saved in:
Bibliographic Details
Main Authors: Junyi Sun, Mengzhao Yang, Daoke Yao, Yongjian Zhou, Xiaobo Hu, Guowu Qian, Yiqiang Yuan, Silin Li, Hong Luo, Shixi Zhang, Guangming Li, Donghua Zhang, Guotao Li, Yanyang Zhang, Xinjun Hu, Zujiang Yu, Guangying Cui, Zhigang Ren
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:View
Subjects:
azvudine
chronic respiratory diseases
real world
SARS‐CoV‐2
Online Access:https://doi.org/10.1002/VIW.20240133
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/VIW.20240133

Similar Items